Skip to main content
Foghorn Therapeutics Inc. (FHTX)
Drugs Health Care
Stock AI
Annual
TTM
Change
Nov 21 Mar 22 May 22 Aug 22 Nov 22 Mar 23 May 23 Aug 23 Nov 23 Mar 24 May 24 Aug 24 Nov 24 Mar 25 May 25 Aug 25 Nov 25 Mar 26 May 26 Aug 26
Price to Earnings
-2.77x
-4.29x
-2.98x
-4.43x
Price to Sales
8.14x
10.32x
7.96x
7.8x
P/E to Growth Ratio
-0.11x
-0.17x
-0.12x
-0.18x
Market Capitalization
$199.5M
$318.8M
$224.7M
$286.5M
Enterprise Value
$116.9M
$238.9M
$138.9M
$221.2M
Book Value
-$89.65M
-$108.5M
-$76.40M
-$81.04M
Tangible Book Value
-$89.65M
-$108.5M
-$76.40M
-$81.04M
Free Cash Flow
-$88.87M
-$86.14M
-$87.41M
-$84.29M
Owner Earnings
-$90.35M
-$90.51M
-$90.40M
-$85.73M
Enterprise Value to Operating Cash Flow
-1.32x
-2.78x
-1.59x
-2.63x
Enterprise Value to Free Cash Flow
-1.32x
-2.77x
-1.59x
-2.62x
EV to EBIT
-1.62x
-3.22x
-1.84x
-3.42x
EV to Sales
4.77x
7.73x
4.92x
6.02x
Enterprise Value to EBITDA
-1.71x
-3.48x
-2x
-3.76x
Price to Book Value
-2.23x
-2.94x
-2.94x
-3.54x
Price to Tangible Book Value
-2.23x
-2.94x
-2.94x
-3.54x
Price to NAV
-2.23x
-2.94x
-2.94x
-3.54x
Price to Net Cash
2.42x
3.99x
2.62x
4.39x
Price to Net Net Working Capital
-0.97x
-1.41x
-1.07x
-1.32x
Price to NCAV
-1.81x
-2.22x
-2.03x
-2.5x
Shiller Price to Earnings
-2.23x
-3.55x
-2.41x
-3.18x
Price to Owner Earnings
-2.21x
-3.52x
-2.49x
-3.34x
Price to Earnings to Growth to Dividend Yield
-0.11x
-0.17x
-0.12x
-0.18x
Net Current Asset Value
-$110.5M
-$143.3M
-$110.5M
-$114.3M
Net Asset Value
-$89.65M
-$108.5M
-$76.40M
-$81.04M
Net Net Working Capital
-$205.2M
-$225.7M
-$210.9M
-$216.3M
Copyright ©2026 Taurigo GmbH. All rights reserved.Taurigo GmbH provides no investment advice. Any analyses, research, ideas, prices, or other information contained on this website are provided as general market information for educational and entertainment purposes only, and do not constitute investment advice. We assume no responsibility for the accuracy, completeness or timeliness of any financial information contained on this site. In particular, we do not constitute an invitation to buy, sell or hold securities or other financial products. We shall not be liable for any loss or damage, including without limitation loss of profits, arising directly or indirectly from use of or reliance on the provided information. Before making any investment decision, you should consider whether it is suitable for your situation and obtain appropriate financial, tax and legal advice.